USD
$0.00
(0.00%
)At Close (As of Oct 22, 2025)
$230.52M
Market Cap
172
P/E Ratio
0.01
EPS
$2.07
52 Week High
$0.85
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $48M |
Total Revenue | $160M |
Cost Of Revenue | $112M |
Costof Goods And Services Sold | $112M |
Operating Income | -$36M |
Selling General And Administrative | $48M |
Research And Development | $11M |
Operating Expenses | $83M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $12M |
Income Before Tax | -$45M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$45M |
Comprehensive Income Net Of Tax | - |
Ebit | -$36M |
Ebitda | -$24M |
Net Income | -$45M |
Field | Value (CAD) |
---|---|
Total Assets | $408M |
Total Current Assets | $262M |
Cash And Cash Equivalents At Carrying Value | $107M |
Cash And Short Term Investments | $107M |
Inventory | $83M |
Current Net Receivables | $37M |
Total Non Current Assets | $146M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $8.1M |
Intangible Assets Excluding Goodwill | $8.1M |
Goodwill | $0 |
Investments | - |
Long Term Investments | $41M |
Short Term Investments | $821K |
Other Current Assets | $35M |
Other Non Current Assets | - |
Total Liabilities | $102M |
Total Current Liabilities | $53M |
Current Accounts Payable | $47M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.1M |
Total Non Current Liabilities | $49M |
Capital Lease Obligations | $4.4M |
Long Term Debt | $25K |
Current Long Term Debt | $60K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $4.5M |
Other Current Liabilities | $5.1M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $306M |
Treasury Stock | - |
Retained Earnings | -$584M |
Common Stock | $853M |
Common Stock Shares Outstanding | $95M |
Field | Value (CAD) |
---|---|
Operating Cashflow | $3.9M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $12M |
Capital Expenditures | $5.3M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$39M |
Cashflow From Financing | $108M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$45M |
Field | Value (USD) |
---|---|
Gross Profit | $48M |
Total Revenue | $160M |
Cost Of Revenue | $112M |
Costof Goods And Services Sold | $112M |
Operating Income | -$36M |
Selling General And Administrative | $48M |
Research And Development | $11M |
Operating Expenses | $83M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $12M |
Income Before Tax | -$45M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$45M |
Comprehensive Income Net Of Tax | - |
Ebit | -$36M |
Ebitda | -$24M |
Net Income | -$45M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
OrganiGram Holdings Inc. (OGI) is a prominent Canadian cannabis producer based in Moncton, New Brunswick, specializing in the creation of high-quality cannabis and cannabis-derived products for both medical and recreational markets. The company is dedicated to innovation and sustainability within the rapidly evolving cannabis industry, utilizing state-of-the-art cultivation facilities and robust distribution networks to optimize its market reach. With a strategic focus on enhancing product offerings and capitalizing on growth opportunities, OrganiGram is well-positioned to thrive in the competitive landscape of cannabis production.